Willingness to receive an HIV vaccine among incarcerated persons
- PMID: 16875723
- PMCID: PMC3249390
- DOI: 10.1016/j.ypmed.2006.06.012
Willingness to receive an HIV vaccine among incarcerated persons
Abstract
Background: Once an HIV vaccine becomes available, high-risk adults will be a target population for vaccination, and HIV vaccination programs for inmates may be a public health priority. Nothing is known about U.S. inmates' willingness to accept an anticipated HIV vaccine while incarcerated. The goal of this study was to examine inmates' attitudes toward a potential HIV vaccine.
Methods: In 2002, we interviewed 153 male and female inmates at the Rhode Island Department of Corrections (RIDOC) using a voluntary, anonymous survey.
Results: Ninety-three percent of inmates indicated they would be willing to receive a hypothetical HIV vaccine while incarcerated. Although 88% of inmates self-reported at least one HIV risk factor, only 20% perceived themselves to be at risk for HIV.
Conclusion: Once an HIV vaccine becomes available, HIV vaccination programs in the correctional setting need to become a public health priority. These would be well received by inmates in Rhode Island.
Similar articles
-
Prisoners' attitudes toward Hepatitis B vaccination.Prev Med. 2004 Jun;38(6):828-33. doi: 10.1016/j.ypmed.2003.12.024. Prev Med. 2004. PMID: 15193905
-
HIV testing experiences among male and female inmates in Rhode Island.AIDS Read. 2007 Sep;17(9):459-64. AIDS Read. 2007. PMID: 17902230
-
Prisoners favour hepatitis C testing and treatment.Epidemiol Infect. 2006 Apr;134(2):243-8. doi: 10.1017/S0950268805004991. Epidemiol Infect. 2006. PMID: 16490126 Free PMC article.
-
Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge.Am J Med. 1993 Dec;95(6):629-35. doi: 10.1016/0002-9343(93)90359-w. Am J Med. 1993. PMID: 8259780 Review.
-
Viral hepatitis in incarcerated adults: a medical and public health concern.Am J Gastroenterol. 2009 Apr;104(4):1024-31. doi: 10.1038/ajg.2008.143. Epub 2009 Feb 24. Am J Gastroenterol. 2009. PMID: 19240708 Review.
Cited by
-
Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults.Public Health Action. 2013 Mar 21;3(1):31-7. doi: 10.5588/pha.12.0102. Public Health Action. 2013. PMID: 26392993 Free PMC article.
-
Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.PLoS One. 2021 Dec 2;16(12):e0260126. doi: 10.1371/journal.pone.0260126. eCollection 2021. PLoS One. 2021. PMID: 34855790 Free PMC article.
-
HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.BMC Public Health. 2014 May 30;14:537. doi: 10.1186/1471-2458-14-537. BMC Public Health. 2014. PMID: 24885970 Free PMC article.
References
-
- Allen MA, Liang TS, LaSalvia T, Tjugum B, Gulakowski RJ, Murguia M. Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States. Acquir Immune Defic Syndr Newsl. 2005;40(5):617–624. - PubMed
-
- Barouch DH, Nabel GJ. Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum Gene Ther. 2005;16(2):149–156. - PubMed
-
- Bureau of Justice Statistics. [Accessed September 19];HIV in prisons, 2003. 2003 Online at http://www.ojp.usdoj.gov/bjs/abstract/hivp03.htm.
-
- Bureau of Justice Statistics. [Accessed April 12];Criminal Sentencing Statistics. 2005 Online at http://www.ojp.usdoj.gov/bjs/sent.htm.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical